Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

19,100 public trials 1,287 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, not recruiting

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 85 locations
View Trial Details
Active, not recruiting

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

NCT07254702

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras Belo Horizonte, Minas Gerais, Brazil
  • Centro de Pesquisas Clínicas Universidade Federal Sergipe, Hospital e Maternidade São João de Deus Laranjeiras, Sergipe, Brazil
  • Fundação Faculdade Regional De Medicina De São José Do Rio Preto São Pedro, São Paulo, Brazil
View Trial Details
Active, not recruiting

A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

NCT07047521

Conditions
Arbovirus Infections, Dengue, Dengue Fever, +8 more
Locations
  • Paratus Clinical Research Western Sydney Blacktown, New South Wales, Australia
  • Emeritus Research Sydney Botany, New South Wales, Australia
  • Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
  • Veritus Research Bayswater, Victoria, Australia
View Trial Details
Active, not recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details

Related conditions